PrintBio Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $21M

  • Investors
  • 12

PrintBio General Information

Description

Developer of a three-dimensional bioprinting and material technology designed to treat disease and congenital medical conditions. The company offers technologies focused on regenerative medicine, solving medical challenges with custom-engineered three-dimensional-printed living transplants, and also develops living tissue implants with structural and functional integrity, enabling healthcare professionals to access safe and functional implant technologies delivering optimal patient outcomes.

Contact Information

Formerly Known As
3D Bio Holdings
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 51-36 35th Street
  • Long Island City, NY 11101
  • United States
+1 (212)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Biotechnology
Therapeutic Devices
Corporate Office
  • 51-36 35th Street
  • Long Island City, NY 11101
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PrintBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 29-Apr-2022 $21M Completed Clinical Trials - General
3. Debt - General 30-Sep-2021 Completed Clinical Trials - General
2. Later Stage VC (Series A) 10-Apr-2019 $8.46M $8.46M Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view PrintBio’s complete valuation and funding history, request access »

PrintBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view PrintBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PrintBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a three-dimensional bioprinting and material technology designed to treat disease and congenital medical co
Other Healthcare Technology Systems
Long Island City, NY
7 As of 2026

Berkeley, CA
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PrintBio Competitors (9)

One of PrintBio’s 9 competitors is Prellis Biologics, a Venture Capital-Backed company based in Berkeley, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Prellis Biologics Venture Capital-Backed Berkeley, CA
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
FluidForm Bio Venture Capital-Backed Waltham, MA
Brinter Venture Capital-Backed Winston-Salem, NC
Frontier Bio Venture Capital-Backed Hayward, CA
You’re viewing 5 of 9 competitors. Get the full list »

PrintBio Patents

PrintBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026152022-A1 Programmable printed mesh constructs Pending 10-Jan-2025

PrintBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PrintBio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aurum Venture Partners Venture Capital Minority
Expa Accelerator/Incubator Minority
Network VC Venture Capital Minority
Vision Capital Ventures Venture Capital Minority
Blue Collective Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

PrintBio FAQs

  • When was PrintBio founded?

    PrintBio was founded in 2014.

  • Where is PrintBio headquartered?

    PrintBio is headquartered in Long Island City, NY.

  • What is the size of PrintBio?

    PrintBio has 7 total employees.

  • What industry is PrintBio in?

    PrintBio’s primary industry is Other Healthcare Technology Systems.

  • Is PrintBio a private or public company?

    PrintBio is a Private company.

  • What is the current valuation of PrintBio?

    The current valuation of PrintBio is .

  • What is PrintBio’s current revenue?

    The current revenue for PrintBio is .

  • How much funding has PrintBio raised over time?

    PrintBio has raised $31.4M.

  • Who are PrintBio’s investors?

    Aurum Venture Partners, Expa, Network VC, Vision Capital Ventures, and Blue Collective are 5 of 12 investors who have invested in PrintBio.

  • Who are PrintBio’s competitors?

    Prellis Biologics, Aspect Biosystems, FluidForm Bio, Brinter, and Frontier Bio are some of the 9 competitors of PrintBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process